Inverse correlation between mRNA expression of plasminogen activator inhibitor-2 and lymph node metastasis in human breast cancer

Japanese Journal of Cancer Research

Volumn 87, Issue 5, 1996, Pages 480-487

  Ishikawa, Noboru ^a   Endo, Yoshio ^a   Sasaki, Takuma ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Breast cancer; Lymph node metastasis; PAI 2; RT PCR

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 2; RECEPTOR; UROKINASE;

ARTICLE; BREAST CANCER; CANCER INVASION; CLINICAL ARTICLE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029954446     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00249.x     Document Type: Article

References (37)

1. Danø, K., Andreasen, P. A., Grøndahl-Hansen, J., Kristensen, P., Nielsen, L. S. and Skriver, L. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res., 44, 139-266 (1985).
2. Duffy, M. J., Reilly, D., O'Sullivan, C., O'Higgins, N., Fennelly, J. J. and Andreasen, P. Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res., 50, 6827-6829 (1990).
3. Ganesh, S., Sier, C. F. M., Griffioen, G., Vloedgraven, H. J. M., de Boer, A., Welvaart, K., van de Velde, C. J. H., van Krieken, J. H. J. M., Verheijen, J. H., Lamers, C. B. H. W. and Verspaget, H. W. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res., 54, 4065-4071 (1994).
4. Grøndahl-Hansen, J., Christensen, I. J., Rosenquist, C., Brünner, N., Mouridsen, H. T., Danø, K. and Blichert-Toft, M. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res., 53, 2513-2521 (1993).
5. Del Vecchio, S., Stoppelli, M. P., Carriero, M. V., Fonti, R., Massa, O., Li, P. Y., Botti, G., Cerra, M., D'Aiuto, G., Esposito, G. and Salvatore, M. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res., 53, 3198-3206 (1993).
6. Saksela, O. and Rifkin, D. B. Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol., 4, 93-126 (1988).
7. Saksela, O., Moscatelli, D. and Rifkin, D. B. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J. Cell Biol., 105, 957-963 (1987).
8. Jensen, P. J. and Rodeck, U. Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF-alpha/EGF receptor. J. Cell. Physiol., 155, 333-339 (1993).
9. Pignatelli, M. E-Cadherin: a biological marker of tumor differentiation. J. Pathol., 171, 81-82 (1993).
10. Otto, T., Rembrink, K., Goepel, M., Meyer-Schwickerath, M. and Rübben, H. E-Cadherin: a marker for differentiation and invasiveness in prostatic carcinoma. Urol. Res., 21, 359-362 (1993).
11. Frixen, U. H. and Nagamine, Y. Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion. Cancer Res., 53, 3618-3623 (1993).
12. Conboy, J. G., Chan, J., Mohandas, N. and Kan, Y. W. Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells. Proc. Natl. Acad. Sci. USA, 85, 9062-9065 (1988).
13. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem., 162, 156-159 (1987).
14. Brünner, N., Boysen, B., Rømer, J. and Spang-Thomsen, M. The nude mouse as an in vivo model for human breast cancer invasion and metastasis. Breast Cancer Res. Treat., 24, 257-264 (1993).
15. Bae, S. N., Arand, G., Azzam, H., Pavasant, P., Torri, J., Frandsen, T. L. and Thompson, E. W. Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res. Treat., 24, 241-255 (1993).
16. Sommers, C. L., Byers, S. W., Thompson, E. W., Torri, J. A. and Gelmann, E. P. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res. Treat., 31, 325-335 (1994).
17. Liotta, L. A., Rao, C. N., and Wewer, U. M. Biochemical interactions of tumor cells with the basement membrane. Annu. Rev. Biochem., 55, 1037-1057 (1986).
18. Liotta, L. A. and Stetler-Stevenson, W. G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res., 51 (Suppl.), 5054s-5059s (1991).
19. Pöllänen, J., Stephenes, R. W. and Vaheri, A. Directed plasminogen activation at the surface of normal and malignant cells. Adv. Cancer Res., 57, 273-328 (1991).
20. Foekens, J. A., Buessecker, F., Peters, H. A., Krainick, U., Putten, W. L. J., Look, M. P., Klijn, J. G. M. and Kramer, M. D. Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer. Cancer Res., 55, 1423-1427 (1995).
21. Nagayama, M., Sato, A., Hayakawa, H., Urano, T., Takada, Y. and Takada, A. Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination. Cancer, 73, 1398-1405 (1994).
22. Testa, J. E. and Quigley, J. P. The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metastasis Rev., 9, 353-367 (1990).
23. Carriero, M. V., Franco, P., Del Vecchio, S., Massa, O., Botti, G., D'Aiuto, G., Stoppelli, M. P. and Salvatore, M. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res., 54, 5445-5454 (1994).
24. Becker, K. F., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Siewert, J. R. and Høfler, H. E-Cadherin gene mutation provide clues to diffuse type gastric carcinomas. Cancer Res., 54, 3845-3852 (1994).
25. Shiozaki, H., Kadowaki, T., Doki, Y., Inoue, M., Tamura, S., Oka, H., Iwazawa, T., Matsui, S., Shimaya, K. and Takeichi, M. Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line. Br. J. Cancer, 71, 250-258 (1995).
26. Riccio, A., Grimaldi, G., Verde, P., Sebastio, G., Boast, S. and Blasi, F. The human urokinase-plasminogen activator gene and its promoter. Nucleic Acids Res., 13, 2759-2771 (1985).
27. Min, H. Y., Semnani, R., Mizukami, I. F., Watt, K., Todd, R. F. and Liu, D. Y. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J. Immunol., 148, 3636-3642 (1992).
28. Loskutoff, D. J., Linders, M., Keijer, J., Veerman, H., Heerikhuizen, H. V. and Pannekoek, H. Structure of the human plasminogen activator inhibitor 1 gene. Biochemistry, 26, 3763-3768 (1987).
29. Ye, R. D., Ahern, S. M., Le Beau, M. M., Lebo, R. V. and Sadler, J. E. Structure of the gene for human plasminogen activator inhibitor-2. J. Biol. Chem., 264, 5495-5502 (1989).
30. 2+-dependent cell adhesion. EMBO J., 6, 3647-3653 (1987).
31. Castles, C. G., Fuqua, S. A. W., Klotz, D. M. and Hill, S. M. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res., 53, 5934-5939 (1993).
32. Albino, A. P., Davis, B. M. and Nanus, D. M. Introduction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res., 51, 4815-4820 (1991).
33. Rappolee, D. A., Mark, D., Banda, M. J. and Werb, Z. Wound macrophages express TGF-α and other growth factor in vivo: analysis by mRNA phenotyping. Science, 241, 708-712 (1988).
34. Oda, T., Kanai, Y., Shimoyama, Y., Nagafuchi, A., Tsukita, S. and Hirohashi, S. Cloning of the human alpha-catenin cDNA and its aberrant mRNA invasion in a human cancer cell line. Biochem. Biophys. Res. Commun., 193, 897-904 (1993).
35. Hülsken, J., Birckmeier, W. and Behrens, J. E-Cadherin and APC complete for the interaction with beta-catenin and the cytoskeleton. J. Cell Biol., 127, 2061-2069 (1994).
36. Iijima, S. N., Hamada, H., Reddy, P. and Kakunaga, T. Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequence in the introns. Proc. Natl. Acad. Sci. USA, 82, 6133-6137 (1985).
37. Schneider, C., Owen, M. J., Banville, D. and Williams, J. G. Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature, 311, 675-678 (1984).